IRIS
ROCCO, ANGELICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.234
EU - Europa 637
NA - Nord America 314
SA - Sud America 162
AF - Africa 18
OC - Oceania 3
Totale 2.368
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 645
RU - Federazione Russa 399
CN - Cina 335
US - Stati Uniti d'America 284
BR - Brasile 126
VN - Vietnam 80
HK - Hong Kong 77
DE - Germania 51
IT - Italia 48
KR - Corea 34
FI - Finlandia 25
FR - Francia 24
GB - Regno Unito 23
IN - India 21
AR - Argentina 18
NL - Olanda 13
AT - Austria 12
CA - Canada 12
MX - Messico 10
PL - Polonia 8
ID - Indonesia 7
UA - Ucraina 7
CO - Colombia 6
IE - Irlanda 6
TR - Turchia 6
ZA - Sudafrica 6
BD - Bangladesh 5
EC - Ecuador 5
ES - Italia 5
IR - Iran 4
JP - Giappone 4
LT - Lituania 4
SE - Svezia 4
AZ - Azerbaigian 3
IQ - Iraq 3
MA - Marocco 3
PY - Paraguay 3
AU - Australia 2
DO - Repubblica Dominicana 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
SN - Senegal 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
CM - Camerun 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
HN - Honduras 1
HT - Haiti 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
VE - Venezuela 1
ZM - Zambia 1
Totale 2.368
Salva come PNG Salva come JPEG
Città #
Singapore 352
Hefei 184
Moscow 85
Hong Kong 77
Beijing 69
Ashburn 48
Seoul 32
Ho Chi Minh City 31
Santa Clara 23
Hanoi 21
Munich 18
Los Angeles 17
Redondo Beach 12
Kochi 11
Naples 11
São Paulo 11
Amsterdam 10
Dallas 10
Helsinki 10
Nuremberg 10
Buffalo 9
Frankfurt am Main 9
San Jose 8
Vienna 8
Castellammare di Stabia 7
Lappeenranta 7
New York 7
Portsmouth 7
Turku 7
Ankara 6
Capaccio 6
Chennai 6
Mexico City 6
Atlanta 5
Chicago 5
Dublin 5
Lauterbourg 5
Rio de Janeiro 5
Wroclaw 5
Belo Horizonte 4
Brooklyn 4
Council Bluffs 4
Düsseldorf 4
Guayaquil 4
Montreal 4
Orem 4
Porto Alegre 4
Stockholm 4
Tokyo 4
Bexley 3
Brasília 3
Bắc Ninh 3
Falkenstein 3
Haiphong 3
Johannesburg 3
London 3
Manassas 3
Poplar 3
Québec 3
San Francisco 3
Seattle 3
Toronto 3
Warsaw 3
Arezzo 2
Baku 2
Bauru 2
Boston 2
Bắc Giang 2
Canelli 2
Catania 2
Denver 2
Erbil 2
Florianópolis 2
Houston 2
Itapetininga 2
Lima 2
Lomas de Zamora 2
Londrina 2
Managua 2
Manchester 2
Marília 2
Nanjing 2
Ninh Bình 2
Quảng Ngãi 2
Rochdale 2
Rome 2
Roubaix 2
Salvador 2
Santo André 2
Surabaya 2
Sydney 2
São Sebastião 2
Tashkent 2
Tehran 2
Tianjin 2
Abuja 1
Accra 1
Amman 1
Anapu 1
Ancona 1
Totale 1.316
Salva come PNG Salva come JPEG
Nome #
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models 119
From the Discovery of Targets to Delivery Systems: How to Decipher and Improve the Metallodrugs’ Actions at a Molecular Level 102
Collagen treatment of complex anorectal fistula: 3 years follow-up 101
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 100
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 99
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 99
Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology 97
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience 96
Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study 94
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 93
DES Y3 + KiDS-1000: Consistent cosmology combining cosmic shear surveys 90
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 89
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 85
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study 83
Cardiovascular prevention in childhood: a consensus document of the Italian Society of Cardiology Working Group on Congenital Heart Disease and Cardiovascular Prevention in Paediatric Age 80
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome 77
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy 73
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study 73
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group 68
Use of vegetable materials for temporary structures. 67
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. 67
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 66
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 63
Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network 60
The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019 59
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis 57
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 56
Circulating innate lymphoid cells are dysregulated in patients with prostate cancer 56
Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database 52
MHD, disruptions and control physics: Chapter 4 of the special issue: on the path to tokamak burning plasma operation 27
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 18
Gamma-Ray Burst Observations by the High-Energy Particle Detector on board the China Seismo-Electromagnetic Satellite between 2019 and 2021 16
The chronic heart failure evolutions: Different fates and routes 15
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe 14
Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915) 8
Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma 6
Totale 2.425
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 0 0 2
2022/20231 1 0 0 0 0 0 0 0 0 0 0 0
2023/202432 0 0 0 0 0 1 7 1 2 4 7 10
2024/2025906 15 17 4 11 12 31 75 89 63 123 370 96
2025/20261.480 212 259 259 242 398 96 14 0 0 0 0 0
Totale 2.425